Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Decreased serum apolipoprotein A1 level predicts poor prognosis of patients with de novo myelodysplastic syndromes

Fig. 3

Overall survival and leukemia-free survival of MDS patients according to the stratified analysis of ApoA1. A Overall survival of 228 patients with primary MDS was stratified by ApoA1 ≤ 1.02 g/L vs. ApoA1 > 1.02 g/L (P < 0.0001). B Leukemia-free survival of 228 patients with primary MDS was stratified by ApoA1 ≤ 1.02 g/L vs. ApoA1 > 1.02 g/L (P = 0.367)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us